ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » North Dakota » Cardiovascular Disease

Top Cardiovascular Disease Prescribers in North Dakota

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
STANLEY DIEDE MD

Cardiovascular Disease

9,626

$591K

582
545 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

23%
prescriptions for brand name drugs

Avg: 20%

$61
Average prescription price

Avg: $47

ROBERT PERCELL MD

Cardiovascular Disease

9,578

$442K

764
693 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

2%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

24%
prescriptions for brand name drugs

Avg: 20%

$46
Average prescription price

Avg: $47

SAMIR TURK MD

Cardiovascular Disease

9,226

$321K

634
589 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

19%
prescriptions for brand name drugs

Avg: 20%

$35
Average prescription price

Avg: $47

WALTER FRANK MD

Cardiovascular Disease

6,773

$295K

478
458 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

21%
prescriptions for brand name drugs

Avg: 20%

$44
Average prescription price

Avg: $47

RALPH MORALES MD

Cardiovascular Disease

6,041

$182K

845
707 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

17%
prescriptions for brand name drugs

Avg: 20%

$30
Average prescription price

Avg: $47

NORMAN ESHOO MD

Cardiovascular Disease

4,934

$245K

383
353 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

26%
prescriptions for brand name drugs

Avg: 20%

$50
Average prescription price

Avg: $47

VALENTINE CHIKWENDU MD

Cardiovascular Disease

4,727

$162K

345
305 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

19%
prescriptions for brand name drugs

Avg: 20%

$34
Average prescription price

Avg: $47

NOAH CHELLIAH MD

Cardiovascular Disease

4,613

$170K

414
388 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

17%
prescriptions for brand name drugs

Avg: 20%

$37
Average prescription price

Avg: $47

RABEEA ABOUFAKHER MD

Cardiovascular Disease

3,566

$152K

387
344 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

22%
prescriptions for brand name drugs

Avg: 20%

$43
Average prescription price

Avg: $47

NICHOLAS MAHR MD

Cardiovascular Disease

3,011

$139K

245
221 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

19%
prescriptions for brand name drugs

Avg: 20%

$46
Average prescription price

Avg: $47

SUSAN FARKAS MD

Cardiovascular Disease

2,800

$132K

448
387 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

17%
prescriptions for brand name drugs

Avg: 20%

$47
Average prescription price

Avg: $47

ABDELHAMID AHMED MD

Cardiovascular Disease

2,311

$87.9K

368
321 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

20%
prescriptions for brand name drugs

Avg: 20%

$38
Average prescription price

Avg: $47

RICHARD HOWARD MD

Cardiovascular Disease

2,197

$111K

194
176 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

27%
prescriptions for brand name drugs

Avg: 20%

$51
Average prescription price

Avg: $47

KARTHIK REDDY MD

Cardiovascular Disease

2,130

$106K

284
253 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

26%
prescriptions for brand name drugs

Avg: 20%

$50
Average prescription price

Avg: $47

EMAD DODIN MD

Cardiovascular Disease

2,105

$84.2K

184
167 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

20%
prescriptions for brand name drugs

Avg: 20%

$40
Average prescription price

Avg: $47

GARFIELD GRIMMETT MD

Cardiovascular Disease

2,061

$190K

233
212 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

22%
prescriptions for brand name drugs

Avg: 20%

$92
Average prescription price

Avg: $47

DAVID CLARDY MD

Cardiovascular Disease

1,974

$102K

366
316 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

16%
prescriptions for brand name drugs

Avg: 20%

$52
Average prescription price

Avg: $47

JOHN RAGAN MD

Cardiovascular Disease

1,886

$53.7K

302
278 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

15%
prescriptions for brand name drugs

Avg: 20%

$28
Average prescription price

Avg: $47

WALLACE RADTKE MD

Cardiovascular Disease

1,631

$86K

309
276 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

17%
prescriptions for brand name drugs

Avg: 20%

$53
Average prescription price

Avg: $47

CRAIG KOUBA MD

Cardiovascular Disease

1,595

$74.2K

364
306 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

18%
prescriptions for brand name drugs

Avg: 20%

$47
Average prescription price

Avg: $47

STEPHEN KORTE MD

Cardiovascular Disease

1,494

$67.1K

197
183 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

29%
prescriptions for brand name drugs

Avg: 20%

$45
Average prescription price

Avg: $47

HEERAIMA MANJUNATH MD

Cardiovascular Disease

1,176

$175K

247
211 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

20%
prescriptions for brand name drugs

Avg: 20%

$148
Average prescription price

Avg: $47

JOHN CRARY MD

Cardiovascular Disease

1,127

$51.9K

192
169 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

17%
prescriptions for brand name drugs

Avg: 20%

$46
Average prescription price

Avg: $47

CHRISTINA MCDOWELL MD

Cardiovascular Disease

1,094

$49.2K

263
227 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

14%
prescriptions for brand name drugs

Avg: 20%

$45
Average prescription price

Avg: $47

THOMAS HALDIS DO

Cardiovascular Disease

928

$41.7K

183
166 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 0%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

16%
prescriptions for brand name drugs

Avg: 20%

$45
Average prescription price

Avg: $47

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank